Mitigating transient arrhythmogenicity in pig following human cardiomyocyte transplantation

To achieve therapeutic cardiac regeneration, the University of Washington Medicine Heart Regeneration Program has been focusing on remuscularization with genuine cardiomyocytes derived from pluripotent stem-cells.

Dr. Nakamura presented his work during the 2023 Society of Toxicology (SOT) conference in Nashville.

This article summarizes some of the key points that were presented during the event and includes the video recording of the talk.

DR. KENTA NAKAMURA M.D., F.A.C.C. at University of Washington, WA, USA

Dr. Nakamura is Director of Preclinical Research at the UW Medicine Heart Regeneration Program. This translational research focuses on pluripotent stem cell-based cardiac remuscularization therapies using various preclinical models to optimize the efficacy, safety, engraftment and maturation of cardiomyocyte transplantation through novel genetic, metabolic, immunomodulatory, antiarrhythmic and delivery strategies.

Dr. Nakamura obtained his medical degree at the University of California, San Francisco and clinical training at the Massachusetts General Hospital/Harvard Medical School with post-doctoral studies at the Massachusetts Institute of Technology. He is an Assistant Professor of Medicine at the University of Washington and directs the Cardiac Catheterization Laboratory at the VA Puget Sound Healthcare System.

By browsing this website, you accept the use of cookies for statistical purposes.

Close Popup
Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are set through our site by our advertising partners.

We use Hubspot to monitor our traffic and to help us AB test new features.

Google Adwords
We use Adwords to track our Conversions through Google Clicks.

Google Tag Manager